Contact Us

TRANSPORTATION NEWS

Xinhua Silk Road: Pien Tze Huang boosts TCM globalization

Dec 18, 2024

BEIJING,Dec. 12,2024-- Zhangzhou Pien Tze Huang Pharmaceutical Co.,Ltd.,a Fujian-based traditional Chinese medicine (TCM) company,has been striving to expand its overseas markets,enhancing the influen

2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

Dec 18, 2024

YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme

Lichen China Limited Announces $2.70 Million Registered Direct Offering

Dec 18, 2024

XIAMEN,China,Dec. 13,2024--Lichen China Limited (Nasdaq: LICN)("Lichen China" or the "Company"),a dedicated financial and taxation service provider inChina today announced that it

Five Companies Honored with 2025 Catalyst Award for Driving Representation and Inclusion for Women

Dec 18, 2024

CIBC,JDE Peet\'s,KPMG,McCarthy Tétrault,and Sanofi to Be Recognized at Annual Gender Equity Conference and Dinner

15 YEARS OLD STUDENTS FROM JOHOR BAGS MOST INNOVATIVE AWARD IN SAMSUNG SOLVE FOR TOMORROW 2024

Dec 18, 2024

Green Tech Innovations Take Center Stage in STEM Competition KUALA LUMPUR,Malaysia,Dec. 13,2024-- Team Terralnnovatorsfrom Johor,made up of three 15-year-old students,has been crowned the winner of th

Alphamab Oncology Presented the Phase II Clinical Data of KN046 in Combination with Axitinib for the Treatment of Advanced NSCLC at ESMO IO Congress 2024

Dec 18, 2024

SUZHOU,China,Dec. 13,2024-- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from a phase II clinical study on PD-L1/CTLA-4 bispecific antibody KN046 in combination with

1 ... 162 163 164 165 166 167 168 ... 352